SII seeks DCGI’s nod for Covishield as booster dose

Many countries have started administering booster doses of vaccine

165
Govt of India
Govt of India

Last Updated on January 13, 2024 by The Health Master

Serum Institute of India has sought from India’s drug regulator approval for Covishield as a booster dose, citing adequate stock of the vaccine in the country and a demand for a booster shot due to the emergence of new coronavirus variants, official sources said.

In an application to the Drugs Controller General of India (DCGI), Prakash Kumar Singh, the Director, Government and Regulatory Affairs at Serum Institute of India (SII) cited that the UK’s Medicines and Healthcare Products Regulatory Agency has already approved the booster dose of AstraZeneca ChAdOx1 nCoV-19 vaccine, they said.

Singh is learnt to have said in the application that as the world continues to face the pandemic situation, many countries have started administering booster doses of C-19 vaccines.

“People of our country as well as citizens of other countries who have already been fully vaccinated with two doses of Covishield are also continuously requesting our firm for booster dose,” an official source quoted Singh as having said in the application on Tuesday.

“You are aware that now there is no shortage of Covishield in our country and the demand for a booster dose is increasing day by day from the people who have already taken two doses in view of the ongoing C-19 pandemic and emergence of new strains.”

It is the need of the hour and a matter of right to health of every individual that they should not be deprived of third dose/booster dose to protect themselves in this pandemic situation, Singh stated.

The Union government has informed Parliament that the National Technical Advisory Group on Immunisation and the National Expert Group on Vaccine Administration for C-19 are deliberating and considering scientific evidence for the need and justification for a booster dose.

Recently, Kerala, Rajasthan, Karnataka and Chhattisgarh have urged the Centre to decide on allowing booster doses of C-19 vaccine diseased amid concerns raised by ‘Omicron’, the new variant of SARS-CoV-2.

The Delhi High Court on November 25 directed the Centre to clarify its stand on administering booster doses to those who are fully vaccinated against coronavirus, saying it does not want a second-wave-like situation on account of being conservative.

Covishield

Covaxin

Sputnik V

Modenra

Govt amends Drugs Rules on Import Licence and registration certificate

Govt is considering revising the DPCO to encourage drug innovation

Govt may impose anti-dumping duty on Pharma API from China

Toxic gas leak in Parawada Pharma City

Govt is considering revising the DPCO to encourage drug innovation

6 arrested for Codeine cough syrup smuggling to Bangladesh

Andhra Pradesh: Doctor gets patent for Plasma Therapy Kit

Retired Pharmacists to motivate serving Pharmacists

No need to panic over new Covid-19 variant: ICMR

Latest Notifications regarding Pharmaceuticals

For informative videos by The Health Master, click on the below YouTube icon:

YouTube Icon

For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:

YouTube Icon

For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:

YouTube Icon

For informative videos on consumer awareness, click on the below YouTube icon:

YouTube Icon
Telegram
WhatsApp
Facebook
LinkedIn
YouTube Icon
Google-news